MetaADEDB 2.0 @ LMMD
pegaptanib
(WLCZTRVUXYALDD-IBGZPJMESA-N)
Structure
SMILES
COCCOC(=O)N[C@H](C(=O)NCCCCCCCOP(=O)(O)C)CCCCNC(=O)OCCOC
Molecular Formula:
C22H44N3O10P
Molecular Weight:
541.573
Log P:
3.3417
Hydrogen Bond Acceptor:
13
Hydrogen Bond Donor:
4
TPSA:
180.56
CAS Number(s):
N/A
Synonym(s)
1.
pegaptanib
2.
Macugen
3.
pegaptanib sodium
External Link(s)
MeSHC495058
PubChem Compound56603655
IUPHAR/BPS Guide to PHARMACOLOGY6836
Therapeutic Target DatabaseD0UF9W
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Detachment of retinal pigment epitheliumFAERS: 1US FAERS
2Anaphylactic shockSIDER
3Anaphylactoid ReactionSIDER
4AngioedemaSIDER
5Anterior chamber inflammationSIDER
6Anterior uveitisSIDER
7Aortic AneurysmSIDER
8ArthritisSIDER
9AstheniaSIDER
10AsthenopiaSIDER
11Back PainSIDER
12BlepharitisSIDER
13BronchitisSIDER
14Carotid artery occlusionSIDER
15CataractSIDER
16Cerebrovascular accidentSIDER
17Chest PainSIDER
18ChillsSIDER
19ConjunctivitisSIDER
20Corneal dystrophySIDER
21Corneal epithelium defectSIDER
22Corneal epithelium disorderSIDER
23Corneal erosionSIDER
24DeafnessSIDER
25Deposit eyeSIDER
26DermatitisSIDER
27Diabetes MellitusSIDER
28DizzinessSIDER
29DyspepsiaSIDER
30Ear and labyrinth disordersSIDER
31EctropionSIDER
32EczemaSIDER
33EndophthalmitisSIDER
34ExcoriationSIDER
35Eye RednessSIDER
36Eye irritationSIDER
37Eye painSIDER
38Eyelid irritationSIDER
39Eyelids pruritusSIDER
40FatigueSIDER
41HeadacheSIDER
42Injection Site ReactionSIDER
43Injection site vesiclesSIDER
44IridocyclitisSIDER
45IritisSIDER
46KeratitisSIDER
47Macular degenerationSIDER
48MeibomianitisSIDER
49Meniere's disease aggravatedSIDER
50MydriasisSIDER
51NasopharyngitisSIDER
52NauseaSIDER
53Night sweatsSIDER
54Ocular HypertensionSIDER
55Ocular discomfortSIDER
56Ocular icterusSIDER
57Optic nerve cuppingSIDER
58PalpitationsSIDER
59PanophthalmitisSIDER
60PhotophobiaSIDER
61PruritusSIDER
62Punctate keratitisSIDER
63Pupillary deformitySIDER
64Retinal Artery OcclusionSIDER
65Retinal Detachment19657986CTD
SIDER
66Retinal Vein OcclusionSIDER
67Retinal exudatesSIDER
68Retinal scarSIDER
69Urinary RetentionSIDER
70Urinary tract infectionSIDER
71VertigoSIDER
72Visual ImpairmentSIDER
73Visual disturbanceSIDER
74Vitreous DetachmentSIDER
75Vitreous floatersSIDER
76Vitreous opacitiesSIDER
77Vitreous prolapseSIDER
78VomitingSIDER
79nervous system disorderSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.